Arrowhead Pharmaceuticals Inc. buy Piper Sandler
Start price
17.12.25
/
50%
€55.98
Target price
17.12.26
€85.13
Performance (%)
1.36%
Price
18.12.25
€56.74
Summary
This prediction is currently active. With a performance of 1.36%, the BUY prediction by Piper_Sandler for Arrowhead Pharmaceuticals Inc. is trending in the right direction. This prediction currently runs until 17.12.26. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Arrowhead Pharmaceuticals Inc. | 1.36% |
| iShares Core DAX® | -0.793% |
| iShares Nasdaq 100 | -2.376% |
| iShares Nikkei 225® | -2.701% |
| iShares S&P 500 | -1.689% |
Comments by Piper_Sandler for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its price target raised by analysts at Piper Sandler from $70.00 to $100.00. They now have an "overweight" rating on the stock.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by Piper_Sandler for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€34.14
19.11.25
19.11.25
€60.47
19.11.26
19.11.26
66.20%
18.12.25
18.12.25
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.00
27.11.24
27.11.24
€42.54
27.11.25
27.11.25
100.00%
28.11.25
28.11.25
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€16.42
08.10.24
08.10.24
€56.53
08.10.25
08.10.25
91.78%
09.10.25
09.10.25

